Hyperion DeFi, Inc. (HYPD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hyperion DeFi, Inc. (HYPD) has a cash flow conversion efficiency ratio of -0.040x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.82 Million) by net assets ($70.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hyperion DeFi, Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Hyperion DeFi, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read HYPD current and long-term liabilities for a breakdown of total debt and financial obligations.
Hyperion DeFi, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hyperion DeFi, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Neptis
WAR:YAN
|
0.243x |
|
CItech Co Ltd
KO:004920
|
-0.021x |
|
Nupur Recyclers Limited
NSE:NRL
|
0.138x |
|
Akme Fintrade India Ltd
NSE:AFIL
|
-0.220x |
|
Koss Corporation
NASDAQ:KOSS
|
-0.025x |
|
Persimmon PLC
LSE:PSN
|
-0.031x |
|
TWL Holdings Bhd
KLSE:7079
|
-0.025x |
|
Hsinjing Holding Co Ltd
TWO:3713
|
0.028x |
Annual Cash Flow Conversion Efficiency for Hyperion DeFi, Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of Hyperion DeFi, Inc. from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see Hyperion DeFi, Inc. market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-13.10 Million | $-30.12 Million | 2.300x | +186.83% |
| 2023-12-31 | $9.00 Million | $-23.84 Million | -2.649x | -81.83% |
| 2022-12-31 | $17.23 Million | $-25.11 Million | -1.457x | -42.82% |
| 2021-12-31 | $20.47 Million | $-20.87 Million | -1.020x | -144.49% |
| 2020-12-31 | $15.30 Million | $-6.38 Million | -0.417x | -- |
About Hyperion DeFi, Inc.
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arct… Read more